NASDAQ: CBIO
Crescent Biopharma Inc Stock Ownership - Who owns Crescent Biopharma?

Insider buying vs selling

Have Crescent Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fairmount Funds Management LLCDirector2025-12-041,360,000$13.41
$18.24MBuy

1 of 1

CBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CBIO insiders and whales buy or sell their stock.

CBIO Shareholders

What type of owners hold Crescent Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Scott D. Sandell101.18%14,056,571$166.71MInsider
Peter J. Barris94.89%13,182,418$156.34MInsider
M. James Barrett94.89%13,182,418$156.34MInsider
Siren LLC61.83%8,589,064$101.87MInsider
Invus Public Equities LP45.47%6,317,565$74.93MInsider
New Enterprise Associates 10 L P35.96%4,995,664$59.25MInsider
New Enterprise Associates 13 LP29.46%4,093,377$48.55MInsider
Fairmount Funds Management LLC19.78%2,747,866$32.59MInsider
Fmr LLC10.18%1,414,680$16.78MInstitution
Fairmount Funds Management LLC9.99%1,387,866$16.46MInstitution

1 of 3

CBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CBIO13.39%86.61%Net BuyingNet Buying
RANI3.32%33.62%Net SellingNet Selling
GNLX19.57%7.44%Net SellingNet Selling
TLSA3.61%0.00%
MOLN9.58%0.00%

Crescent Biopharma Stock Ownership FAQ

Who owns Crescent Biopharma?

Crescent Biopharma (NASDAQ: CBIO) is owned by 81.47% institutional shareholders, 527.08% Crescent Biopharma insiders, and 0.00% retail investors. Scott D. Sandell is the largest individual Crescent Biopharma shareholder, owning 14.06M shares representing 101.18% of the company. Scott D. Sandell's Crescent Biopharma shares are currently valued at $166.71M.

If you're new to stock investing, here's how to buy Crescent Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.